NCT05048758

Brief Summary

Adverse childhood experiences (ACE) and their relation to the development of an alcohol use disorder (AUD) will be measured with functional magnetic resonance imaging (fMRI).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
43

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Nov 2021

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 8, 2021

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 17, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

November 22, 2021

Completed
2.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 17, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 17, 2024

Completed
Last Updated

March 29, 2024

Status Verified

March 1, 2024

Enrollment Period

2.2 years

First QC Date

September 8, 2021

Last Update Submit

March 28, 2024

Conditions

Outcome Measures

Primary Outcomes (7)

  • fMRI to assess group and within-subjects differences in task-specific brain activation patterns: Stress-sensitivity

    Stress-sensitivity: Imaging Stress Task to assess neural activation patterns during mental arithmetic tasks with negative feedback

    fMRI measurement at one day only (day of fMRI experiment)

  • fMRI to assess group and within-subjects differences in task-specific brain activation patterns: Emotion processing

    Emotion-processing: emotional face-/form-matching task to assess neural activation patters of emotion processing

    fMRI measurement at one day only (day of fMRI experiment)

  • fMRI to assess group and within-subjects differences in task-specific brain activation patterns: Alcohol cue-reactivity

    Alcohol cue-reactivity: pictures of alcoholic beverages to assess neural alcohol-cue reactivity

    fMRI measurement at one day only (day of fMRI experiment)

  • fMRI to assess group differences in task-specific brain activation patterns: Response inhibition

    Response inhibition: Stop Signal Task (variation of go/no-go) to assess response inhibition.

    fMRI measurement at one day only (day of fMRI experiment)

  • fMRI to assess group differences in task-specific brain activation patterns: Working memory

    Working memory: n-back task (continuous performance) to assess working memory function.

    fMRI measurement at one day only (day of fMRI experiment)

  • Long-term alcohol consumption

    Self-report in longitudinal sample measured with the LDH interview

    2 - 2.5 year follow-up after first project

  • Short-term alcohol consumption

    Self-report in whole sample measured with the Form 90 interview

    3-month follow-up after current project

Secondary Outcomes (3)

  • Hormonal stress response using salivary cortisol level

    Normal awakening response on a subject's regular week-day (0, 0.5, 8 and 14 hours after wake-up)

  • Hormonal stress response using salivary cortisol level

    day of fMRI experiment, at -45, -22, -10 minutes before and 35, 45, 60, 75 and 90 minutes after onset of stress induction

  • GWAS and especially glutamatergic, serotonergic single-nucleotide polymorphisms

    Blood sample at one day only (day of fMRI experiment)

Study Arms (1)

Individuals with AUD + varying levels of ACE

Individuals with alcohol use disorder (AUD) and varying levels of adverse childhood experiences (ACE)

Other: No intervention

Interventions

No intervention

Also known as: Observational study
Individuals with AUD + varying levels of ACE

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients from the Addiction Clinic at the Central Institute of Mental Health (Mannheim, Germany), as well as residents predominantly from the Mannheim/Heidelberg area who answered an open call to participate in this study.

You may qualify if:

  • Male and female
  • Age between 18 and 65
  • Normal or correctable eyesight
  • Sufficient ability to communicate with the investigators, to answer questions in oral and written form
  • "Fully Informed Consent"
  • "Written Informed Consent"
  • Individuals with alcohol use disorder according to DSM-5 or 'heavy drinking' (alcohol intake \> 40g/ more than 5 days (women) \& 60g/ more than 5 days (men) and varying levels of adverse childhood experiences

You may not qualify if:

  • Withdrawal of the declaration of consent
  • Severe internal, neurological and psychiatric comorbidities
  • Pharmacotherapy with psychoactive substances within the last 14 days (except treatment with SSRI/SNRIs for at least 28 days)
  • Axis-I disorder according to ICD-10 and DSM 5 (except tobacco and alcohol use disorder, substance abuse with less than 2(11) criteria according to DSM-5, mild depressive episode, adaptation disorder and specific phobia within the last 12 months)
  • Positive urin drug screening (cannabis, amphetamine, opiates, benzodiazepines, cocaine)
  • Withdrawal symptoms (CIWA-R \> 7)
  • Intoxication at time of investigation (breathalyzer \> 0.3‰)
  • Suicidal tendency or potential danger for others

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Klinik für Abhängiges Verhalten, Zentralinstitut für Seelische Gesundheit

Mannheim, Baden-Wurttemberg, 68159, Germany

Location

Related Publications (1)

  • Turkmen C, Machunze N, Tan H, Gerhardt S, Kiefer F, Vollstadt-Klein S. Vulnerability for alcohol use disorder after adverse childhood experiences (AUDACE): protocol for a longitudinal fMRI study assessing neuropsychobiological risk factors for relapse. BMJ Open. 2022 Jun 30;12(6):e058645. doi: 10.1136/bmjopen-2021-058645.

Biospecimen

Retention: SAMPLES WITH DNA

Saliva (stress hormones) Blood (genotyping)

MeSH Terms

Conditions

AlcoholismPsychological Trauma

Interventions

Observation

Condition Hierarchy (Ancestors)

Alcohol-Related DisordersSubstance-Related DisordersChemically-Induced DisordersMental DisordersStress Disorders, TraumaticTrauma and Stressor Related Disorders

Intervention Hierarchy (Ancestors)

MethodsInvestigative Techniques

Study Officials

  • Sabine Vollstaedt-Klein, PhD

    Central Institute of Mental Health, Mannheim

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 8, 2021

First Posted

September 17, 2021

Study Start

November 22, 2021

Primary Completion

January 17, 2024

Study Completion

January 17, 2024

Last Updated

March 29, 2024

Record last verified: 2024-03

Locations